CVKD

Cadrenal Therapeutics, Inc. Common StockNASDAQHealthcare

$4.70-1.06%ClosedMarket Cap: $11.0M

As of 2026-04-06

Valuation

P/E (TTM)

—

PEG

—

P/B

3.39

P/S

0.00

EV/EBITDA

-0.52

DCF Value

$1.72

FCF Yield

-116.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-333.3%

ROA

-305.9%

ROIC

-491.5%

Income Statement

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q4 2025	$0.00	NaN%	$-3.1M	$-3.0M	$-1.37	—
FY 2025	$0.00	NaN%	$-13.5M	$-13.2M	$-6.64	—
Q3 2025	$0.00	-Infinity%	$-2.7M	$-2.7M	$-1.31	—
Q2 2025	$0.00	NaN%	$-3.7M	$-3.7M	$-1.87	—
Q1 2025	$0.00	-Infinity%	$-3.9M	$-3.8M	$-2.09	—
Q4 2024	$0.00	NaN%	$-4.3M	$-4.2M	$-2.75	—
FY 2024	$0.00	NaN%	$-11.0M	$-10.7M	$-8.73	—
Q3 2024	$0.00	NaN%	$-2.5M	$-2.4M	$-2.18	—
Q2 2024	$0.00	NaN%	$-2.5M	$-2.4M	$-2.24	—
Q1 2024	$0.00	NaN%	$-1.8M	$-1.7M	$-1.55	—
Q4 2023	$0.00	NaN%	$-1.3M	$-1.1M	$-1.32	—
FY 2023	$0.00	NaN%	$-7.6M	$-8.4M	$-9.63	—